Liver Disease Treatment Market Analysis & Forecast 2024-2030

Liver Disease Treatment Market Report by Product Type (Anti-Rejection Drugs/ Immunosupressants, Chemotherapy Drugs, Targeted therapy, Vaccines ) by Application /End User (Adult, Children ) by Industry Analysis, Volume, Share, Growth, Challenges, Trends, and Forecast 2024-2030, Regional Outlook ( North America, Europe, Asia-Pacific, Middle-East, Africa)

Report Code: PSMR- 1127          Category: Pharmaceutical          Region :  Global         Report Format :                  

 Request Free Sample


    ×

     Table of Contents

    Global Liver Disease Treatment Market is expected to reach USD 47460.72 million by 2030 with CAGR of 11.2% between 2024 and 2030

    Liver disease is any disturbance of liver function that causes illness. Liver disease is also referred to as hepatic disease. Liver disease is a broad term that covers all the potential problems that cause the liver to fail to perform its designated functions. There are different causes of liver disease which include alcohol abuse, cirrhosis, cells inflamentation e.g. hepatitis, obstruction of bile flow e.g. cholestasis, blood flow to the liver may be compromised and many more.
     

    Liver disease treatment market is rapidly growing due to aging population, excessive alcohol consumptions, changing lifestyle patterns, government and NGO awareness programs, increasing consumption of unhealthy fast food diets, increasing prevalence of liver diseases and rising investment in research and development. Strict government regulations for drug approval, high cost involved in R&D increases prices of drugs, side effects happened while liver disease medications are some of the factors that are acting as barriers for the growth of this market.
     

    North America is the largest liver disease treatment market followed by Europe and Asia pacific. Well-established healthcare infrastructure, high level of awareness, higher healthcare spending and developed regulatory framework are main factors for growth of liver disease treatment market in North America and Europe. Asia Pacific will remain as the fastest growing market in forecast period due to the high-untapped opportunities, growing medical tourism industry, supportive government initiatives, increasing disposable income and improving healthcare infrastructure and increasing investments by manufacturers.
     

    Liver Disease Treatment Market : Product Type

    • Anti-Rejection Drugs/ Immunosuppressant
    • Chemotherapy Drugs
    • Targeted therapy
    • Vaccines

    Liver Disease Treatment Market: Application

    • Adult
    • Children

    Liver Disease Treatment Market : Competitive Analysis

    • Gilead Science
    • Bayer AG
    • AstraZeneca
    • GlaxoSmithKline
    • Merck & Co
    • Sanofi
    • Pfizer
    • F. Hoffmann-La Roche
    • Novartis AG
    • Johnson &Johnson

    Geographical analysis of Liver Disease Treatment Market:

    • North America
      • U.S.A
      • Canada
    • Europe
      • France
      • Germany
      • Spain
      • UK
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South East Asia
    • Latin America
      • Brazil
    • Middle East and Africa

    Global Liver Disease Treatment Market Report delivers a comprehensive analysis of the following parameters:

    • Market Forecast for 2024-2030
    • Market growth drivers
    • Challenges and Opportunities
    • Emerging and Current market trends
    • Market player Capacity, Production, Revenue (Value)
    • Supply (Production), Consumption, Export, Import analysis
    • End user/application Analysis

    Report Coverage

    Parameters Details

    Base Year

    2023

    Historical Data

    2018-2023

    Forecast Data

    2024-2030

    Base Year Value (2023)

    USD 22573.6 million

    Forecast Value (2030)

    USD 47460.72 million

    CAGR (2022 to 2028)

    11.2 %

    Regional Scope

    North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW


    Frequently Asked Questions (FAQ)


    Liver Disease Treatment Market was valued at around USD 22573.6 million in 2023 & estimated to reach USD 47460.72 million by 2030.




    Liver Disease Treatment Market is likely to grow at compounded annual growth rate (CAGR) of 11.2% between 2024 to 2030.












    Yes, the report includes COVID 19 impact on the market.



    Purchase Options

      Online Access $2450

      PDF Access $3550

      PDF + Dashboard $4050
        Access

    Inquire Before Buying

    Please fill below details:

      ×
      Free Customization

      We are committed to offering 100 % free customization while purchasing.



        Access the FREE Sample

        Receive a detailed insight into the Liver Disease Treatment Market research study with our FREE sample report delivered straight to your email. The report covers major market factors such as Revenue, Forecast, Top companies insight, Regional analysis, Market trends & more.

         Request Free Sample


          ×